Close
ACHEMA MIDDLE EAST 2026

Micromeritics Announces Instrument Grant to the University of Georgia

AI Summary

Micromeritics’ Instrument Grant Committee has recently selected its latest grant recipient.

A TriStar II Plus 3030, NanoPlus 3 and Flowprep was awarded to the University of Georgia College of Pharmacy.

Michael Bartlett PhD said: “By partnering with Micromeritics, the University of Georgia College of Pharmacy will be able expose students in the department of Pharmaceutical and Biomedical Sciences, as well as our PharmD and graduate programs to techniques used in the characterisation of drug substances and drug delivery systems.”

The enrollment in these combined programs is more than 700 students.

Dr Bartlett has published 120 peer reviewed manuscripts and received more than 7.7 million dollars in research funding from federal agencies and industries.

In the past, Dr Bartlett was named the College of Pharmacy Teaching of the Year in 2002 and was recognised as an AAPS Fellow in 2011.

He is editor-in-chief of the international journal Biomedical Chromatography and also serves in the editorial advisory boards of the Journal of Chromatography B and Analytical Methods.

Micromeritics president Preston Hendrix appointed a special Grant Selection Committee to ensure the success and effectiveness of the program.

Micromeritics’ Instrument Grant Program is intended to provide particle characterisation instruments to non-profit universities and research organisations to foster and support meritorious research projects.

A maximum of one instrument / integrated system will be awarded per calendar quarter.

Applications may be submitted at any time in accordance with application instructions and will remain active for a period of one year from the date of submission.

Visit the Grant Program website for a detailed grant description, application requirements and an application.

Senior pharmaceutical decision - makers don’t consume every piece of content. They have sources they trust. Pharma Advancement is one of them.

Reaching this audience means appearing where they already are — inside trusted editorial that covers the full pharmaceutical and life sciences value chain. Our 2026 Media Pack shows you where to be seen:

Magazine & Digital

Where pharmaceutical decision - makers go to understand what’s coming next. Your brand belongs in that conversation.

Insights & Reports

The analysis and research the sector references when it matters most. Being part of it positions you differently.

Brand Authority

The companies that show up consistently in trusted editorial don’t need to explain who they are. They already are.

SUBSCRIBE OUR NEWSLETTER

WHITE PAPERS

RELATED ARTICLES